atropine

Drug ingredientActive Shortage

This drug ingredient is in active FDA shortage. At least one manufacturer cannot meet demand.

Molecular structure of 51-55-8

Where It Comes From

10 FDA-registered drug labelers
Boehringer Ingelheim Pharma GmbH and Co. KG
Deseret Biologicals, Inc.
Green Earth Health Inc.
Meridian Medical Technologies LLC
MINSHENG GROUP SHAOXING PHARMACEUTICAL CO,. LTD.
Professional Complementary Health Formulas
Rafa Laboratories, Ltd.
Rolabo Outsourcing, S.L.
Siegfried Grafton, Inc.
Vitality Works, Inc.

Why It Matters

Sectors
Health
Downstream Uses

Appears in 5 drug and cosmetic product listings (FDA).

  • Mdfarma COLD and FLU Relief
  • Atropen Auto-Injector
  • Rage
  • NRV-Systemic
  • Low Back Pain Drops 2041
FDA Shortage Status
Active Shortage
Shortage History
current

Atropine Sulfate Injection

01/01/2012

Unavailable

to be discontinued

Atropine Sulfate Injection

11/07/2025

current

Atropine Sulfate Injection

01/01/2020

Unavailable

current

Atropine Sulfate Injection

01/01/2012

Available

current

Atropine Sulfate Injection

01/01/2020

Available

current

Atropine Sulfate Injection

12/20/2023

Available

Chemical Identity

CAS51-55-8
PubChem CID174174
DTXSIDDTXSID4020113
FormulaC17H23NO3
Mol. Weight289.4 g/mol
SMILESCN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3

Data Sources

1741742026-04-07

https://pubchem.ncbi.nlm.nih.gov/rest/pug/compound/name/atropine/cids/JSON

Archive: data/sources/pubchem_name/atropine.json

CAS 51-55-82026-04-24

https://www.epa.gov/tsca-inventory

Archive: data/sources/tsca/tsca_inventory.csv

CAS 51-55-82026-06-13

https://api.fda.gov/drug/shortages.json

Archive: data/sources/fda/shortages/shortages.json